HGC Investment Management Inc. - BIOTECH ACQUISITION COMPANY ownership

BIOTECH ACQUISITION COMPANY's ticker is BIOTW and the CUSIP is G1125A116. A total of 53 filers reported holding BIOTECH ACQUISITION COMPANY in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HGC Investment Management Inc. ownership history of BIOTECH ACQUISITION COMPANY
ValueSharesWeighting
Q4 2022$151
-99.8%
2,429,166
+100.0%
0.01%
+40.0%
Q3 2022$73,000
-81.9%
1,214,583
-50.3%
0.01%
-58.3%
Q2 2022$403,000
+38.0%
2,443,365
+101.0%
0.01%
-29.4%
Q1 2022$292,000
-19.8%
1,215,782
+120.7%
0.02%
-26.1%
Q4 2021$364,000550,9500.02%
Other shareholders
BIOTECH ACQUISITION COMPANY shareholders Q2 2022
NameSharesValueWeighting ↓
Radcliffe Capital Management, L.P. 202,950$2,009,0000.05%
Kingstown Capital 300,000$27,0000.04%
RAMIUS ADVISORS LLC 567,986$51,0000.02%
BOOTHBAY FUND MANAGEMENT, LLC 88,875$880,0000.02%
Q Global Advisors, LLC 300,000$27,0000.02%
MARSHALL WACE, LLP 575,000$5,693,0000.01%
HGC Investment Management Inc. 2,443,365$403,0000.01%
Corbin Capital Partners, L.P. 464,062$42,0000.01%
LMR Partners LLP 50,000$495,0000.01%
Telemetry Investments, L.L.C. 153,694$6,0000.01%
View complete list of BIOTECH ACQUISITION COMPANY shareholders